IDiyas

For the Inventor, By the Inventor

Mechelen, Belgium

Martin James Inglis Andrews

USPTO Granted Patents = 16 

 

Average Co-Inventor Count = 6.3

ph-index = 4

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal9 out of 116 
 
Galapagos Nv
 patents
silverMedal7 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents

Years Active: 2009-2020

Loading Chart...
Loading Chart...
16 patents (USPTO):
1. 10568867 - Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis (2020-02-25),
2. 9895347 - Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis (2018-02-20),
3. 9351955 - Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis (2016-05-31),
4. 9133210 - Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis (2015-09-15),
5. 9006237 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2015-04-14),
6. 8178530 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-05-15),
7. 8173656 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-05-08),
8. 8148369 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-04-03),
9. 8138193 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-03-20),
10. 8133895 - Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2012-03-13),
11. 8012983 - Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases (2011-09-06),
12. 7977352 - Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases (2011-07-12),
13. 7951818 - Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases (2011-05-31),
14. 7915256 - Triazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2011-03-29),
15. 7893058 - Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases (2011-02-22),

Title: The Innovative Journey of Martin James Inglis Andrews

Introduction:

Martin James Inglis Andrews is a visionary inventor based in Mechelen, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Martin James Inglis Andrews holds several patents in the areas of renewable energy technologies, artificial intelligence, and sustainable transportation solutions.

Career Highlights:

With a career spanning over two decades, Martin James Inglis Andrews has worked with leading research institutions and tech companies to develop cutting-edge solutions that have revolutionized various industries.

Collaborations:

Throughout his career, Martin James Inglis Andrews has collaborated with top engineers, scientists, and designers to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of numerous projects.

Conclusion:

Martin James Inglis Andrews continues to push the boundaries of innovation, inspiring the next generation of inventors and leaving a lasting impact on the world of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…